Bellevue Life Sciences Acquisition logo
Bellevue Life Sciences Acquisition
BLAC | NASDAQ
Chart Builder DCF Calculator
$3.01
-$3.72 (-55.27%)
At close: Feb 14, 2025, 04:00 PM ET

Bellevue Life Sciences Acquisition Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
2.91M – – – – –
2.31M – – – – –
592.91K – – – – –
-18.34M -3.52M -1.83M -35.39K -3.31K -23.81K
– 2.18K 2.78M – – –
-28.89M -2.12M 944.59K -35.39K -3.31K -23.81K
-28.89M -2.41M 403.78K -35.39K -3.31K -23.81K
18.93M 3.53M 1.83M 35.39K 3.31K 23.81K
– – – – – –
– – – – – –
18.93M 3.53M 1.83M 35.39K 3.31K 23.81K
– -43.01K – – – –
– – – – – –
21.24M – 1.83M 35.39K 3.31K 23.81K
– 296K 540.81K – – –
– 4.48M 7.69M 9.06M 7.93M 7.89M
– 4.48M 7.72M 9.06M 7.93M 7.89M
– -0.54 0.07 0 0 0
– -0.54 0.07 0 0 0
-18.34M -3.53M 3.72M 193.1K 233.25K -23.81K
– – 944.59K -35.39K -3.31K -23.81K
– – 2.78M 228.49K 236.56K 206.3K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.